トランスレーショナル生物医学

  • ISSN: 2172-0479
  • ジャーナル h-index: 16
  • 雑誌引用スコア: 5.91
  • ジャーナルのインパクトファクター: 3.66
インデックス付き
  • Jゲートを開く
  • Genamics JournalSeek
  • ジャーナル目次
  • 研究聖書
  • グローバル インパクト ファクター (GIF)
  • 中国国家知識基盤 (CNKI)
  • サイテファクター
  • シマゴ
  • 電子ジャーナルライブラリ
  • 研究ジャーナル索引作成ディレクトリ (DRJI)
  • OCLC-WorldCat
  • プロクエスト召喚
  • パブロン
  • ミアル
  • 大学補助金委員会
  • ジュネーブ医学教育研究財団
  • Google スカラー
  • シェルパ・ロメオ
  • 秘密検索エンジン研究所
  • リサーチゲート
このページをシェアする

抽象的な

Nonalcoholic fatty liver disease-An update on biomarkers and disease severity

Dr. Nabaneeta Mahata

Nonalcoholic fatty liver disease is a chronic liver disease with prevalence 9-40 percent in different areas of the world. It is estimated that it will become the most common cause for liver transplantation in the coming years. The major causes implicated for fatty liver who consume no or minimal alcohol are toxins environmental like carbon tetrachloride, ethionine, hepatitis B and C, chemicals like insecticides, pesticides, excess fat diet or defective nutrition like protein deficiency, essential nutrient deficiency like vitamin B 12, choline, methionine. In this research biochemical parameters like fasting glucose, insulin, Kidney function tests, liver function tests, lipid profile, serum electrolytes, total proteins and albumin, LDH and others were measured. Two novel biomarkers Adiponectin and Leptin were also measured with Enzyme linked immunosorbent assay. The extent and severity of these biochemical markers were statistically correlated with fibroscan, an established imaging study of liver which quantifies the extent of fatty infiltration called steatosis expressed in kilopascals and controlled attenuated parameters CAP expressed in decibels per meter. The study showed that there may be a correlation of these parameters with disease severity especially of Adiponectin. It may also be used as a therapeutic target in NAFLD.

免責事項: この要約は人工知能ツールを使用して翻訳されており、まだレビューまたは確認されていません